U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 3447

1.
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
Zachary Braunstein, Eric McLaughlin, Miguel Ruiz, Lai Wei, Naresh Bumma, Don Benson, Srinivas Devarakonda, Maria Chaudhry, Abdullah Khan, Francesca Cottini, Walter Hanel, Robert Baiocchi, Catherine Chung, Daniel Addison, Nina Couette, Alexa Meara, Wael Jarjour, Pierluigi Porcu, Anjali Mishra, John C. Reneau, Ashley E. Rosko, Jonathan E. Brammer
Front Oncol. 2022; 12: 858426. Published online 2022 Apr 29. doi: 10.3389/fonc.2022.858426
PMCID:
PMC9106372
ArticlePDF–1.0M
2.
Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
Rasika Jinadasa, Gabriel Balmus, Lee Gerwitz, Jamie Roden, Robert Weiss, Gerald Duhamel
J Vis Exp. 2011; (50): 2598. Published online 2011 Apr 3. doi: 10.3791/2598
PMCID:
PMC3169248
ArticlePDF–208K
3.
Leukemia-derived growth factor (non-interleukin-2) produced by murine lymphoma T-cell lines.
E F Hays, D Goodrum, M Bessho, S Kitada, C H Uittenbogaart
Proc Natl Acad Sci U S A. 1984 Dec; 81(24): 7807–7811. doi: 10.1073/pnas.81.24.7807
PMCID:
PMC392241
SummaryPage BrowsePDF–888K
4.
Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines.
H L Ostergaard, D A Shackelford, T R Hurley, P Johnson, R Hyman, B M Sefton, I S Trowbridge
Proc Natl Acad Sci U S A. 1989 Nov; 86(22): 8959–8963. doi: 10.1073/pnas.86.22.8959
PMCID:
PMC298410
SummaryPage BrowsePDF–1.3M
5.
XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways
Nitin Chakravarti, Amy Boles, Rachel Burzinski, Paola Sindaco, Colleen Isabelle, Kathleen McConnell, Anjali Mishra, Pierluigi Porcu
Sci Rep. 2024; 14: 9305. Published online 2024 Apr 23. doi: 10.1038/s41598-024-59994-5
PMCID:
PMC11039474
ArticlePDF–6.1M
6.
Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model
G. Raes, J. Van Ginderachter, Yuan Qing Liu, L. Brys, Kristiaan Thielemans, Patrick De Baetselier, Anja Geldhof
Cancer Immunol Immunother. 1997 Dec; 45(5): 257–265. doi: 10.1007/s002620050441
PMCID:
PMC11037619
ArticlePDF–407K
7.
Primary pancreatic peripheral T-cell lymphoma: A case report
Yan-Liang Bai, Li-Jie Wang, Hui Luo, Ya-Bin Cui, Jin-Hui Xu, Hui-Jie Nan, Pei-Yao Yang, Jun-Wei Niu, Ming-Yue Shi
World J Gastrointest Oncol. 2024 Apr 15; 16(4): 1668–1675. Published online 2024 Apr 15. doi: 10.4251/wjgo.v16.i4.1668
PMCID:
PMC11037062
ArticlePDF–5.0M
8.
Novel agents and regimens in relapsed or refractory peripheral T-cell lymphoma: latest updates from 2023 ASH annual meeting
Huageng Huang, Wei Zhang, Xinyi Deng, He Huang, Zhao Wang, Huangming Hong, Tongyu Lin
Exp Hematol Oncol. 2024; 13: 44. Published online 2024 Apr 22. doi: 10.1186/s40164-024-00510-w
PMCID:
PMC11036626
ArticlePDF–633K
9.
Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma
Simeng Gu, Xin Wang, Jingqiu Zhou, Shanshan Du, Ting Niu
Front Oncol. 2024; 14: 1373127. Published online 2024 Apr 9. doi: 10.3389/fonc.2024.1373127
PMCID:
PMC11035758
ArticlePDF–1.3M
10.
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
Erin Gatza, Craig Y. Okada
Cancer Immunol Immunother. 2006 Apr; 55(4): 420–432. Published online 2005 Jul 15. doi: 10.1007/s00262-005-0006-9
PMCID:
PMC11030804
ArticlePDF–969K
11.
Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins
Mieun Lee, Claudia Kistler, Tanja B. Hartmann, Fang Li, Reinhard Dummer, Edgar Dippel, Nina Booken, Claus D. Klemke, Dirk Schadendorf, Stefan B. Eichmüller
Cancer Immunol Immunother. 2007 Jun; 56(6): 783–795. Published online 2006 Nov 7. doi: 10.1007/s00262-006-0239-2
PMCID:
PMC11030727
ArticlePDF–584K
12.
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy
Toshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara, Yui Hirata, Kan Kishibe, Yuki Komabayashi, Seigo Ueda, Miki Takahara, Takumi Kumai, Kei Ishibashi, Akemi Kosaka, Naoko Aoki, Kensuke Oikawa, Yuji Uno, Naoko Akiyama, Masatoshi Sado, Hidehiro Takei, Esteban Celis, Yasuaki Harabuchi, Hiroya Kobayashi
Cancer Immunol Immunother. 2017 Jul; 66(7): 877–890. Published online 2017 Mar 27. doi: 10.1007/s00262-017-1987-x
PMCID:
PMC11028583
ArticlePDF–6.5M
13.
A Case of Secondary Hemophagocytic Lymphohistiocytosis in a Patient With T-cell Lymphoma
Bishara Jahshan, Anna B Owczarczyk, Hamed Daw, Abdo Haddad
Cureus. 2024 Mar; 16(3): e56558. Published online 2024 Mar 20. doi: 10.7759/cureus.56558
PMCID:
PMC11028014
ArticlePDF–742K
14.
Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis
Chun Li Yang, Xi Chen, Hui Jie Zhou, Wan Chun Wu, Li Qun Zou
J Hematol. 2024 Apr; 13(1-2): 46–51. Published online 2024 Apr 9. doi: 10.14740/jh1242
PMCID:
PMC11027771
ArticlePDF–1.4M
15.
Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity
Abanoub Gabra, Joanna Polanco, Shrija Thapa, Sumit Sawhney, Alexey Glazyrin
J Hematol. 2024 Apr; 13(1-2): 29–33. Published online 2024 Apr 9. doi: 10.14740/jh1203
PMCID:
PMC11027770
ArticlePDF–2.7M
16.
Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model
Saptaswa Dey, Pablo Augusto Vieyra-Garcia, Aaroh Anand Joshi, Slave Trajanoski, Peter Wolf
Front Immunol. 2024; 15: 1255859. Published online 2024 Apr 5. doi: 10.3389/fimmu.2024.1255859
PMCID:
PMC11026597
ArticlePDF–6.6M
17.
Analysis of the treatment and prognosis of 266 cases of extranodal natural killer/T-cell lymphoma, nasal type in a single medical center
Lei Yang, Liqiang Wei, Xin Li, Jia Cong, Jin Ye, Na Yao, Jing Yang, Liang Wang, Jingwen Wang
Front Oncol. 2024; 14: 1388564. Published online 2024 Apr 3. doi: 10.3389/fonc.2024.1388564
PMCID:
PMC11021712
ArticlePDF–7.3M
18.
Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV+ Cells (KROG 18-09)
Tae Hoon Lee, Hyun Ju Kim, Jong Hoon Lee, Jeongshim Lee, Jin Hee Kim, Dongryul Oh, Keun-Yong Eom
Cancer Res Treat. 2024 Apr; 56(2): 688–696. Published online 2023 Dec 11. doi: 10.4143/crt.2023.1049
PMCID:
PMC11016645
ArticlePDF–1.8M
19.
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea
Ji Yun Lee, Ji Hyun Kwon, Joon Young Hur, Jun Ho Yi, Ji Hyun Lee, Hyungwoo Cho, Young Rok Do, Jae-Cheol Jo, Hye Jin Kang, Yougil Koh, Won Sik Lee, Sung Nam Lim, Sang Eun Yoon, Seok Jin Kim, Jeong-Ok Lee
Cancer Res Treat. 2024 Apr; 56(2): 681–687. Published online 2023 Nov 10. doi: 10.4143/crt.2023.1042
PMCID:
PMC11016643
ArticlePDF–1.5M
20.
A Rare Case of Extranodal Natural Killer/T-cell Lymphoma, Nasal Type Associated With Hemophagocytic Lymphohistiocytosis in a Patient With Recurrent Sinusitis
Bryce R Christensen, Chung-ting J Kou, Lauren E Lee
Cureus. 2024 Mar; 16(3): e56237. Published online 2024 Mar 15. doi: 10.7759/cureus.56237
PMCID:
PMC11016311
ArticlePDF–1.2M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center